Cargando…
Pharmacokinetics and Pharmacodynamics of Recombinant Human EPO-Fc Fusion Protein In Vivo
In this study, the in vivo pharmacokinetics and pharmacodynamics of a novel recombinant human erythropoietin (rhEPO) Fc fusion protein, rhEPO-Fc, were studied in both rodents and rhesus monkeys. Animal models of anemia induced by irradiation, cyclophosphamide and partial renal ablation were used to...
Autores principales: | Shi, Xunlong, Yang, Jianjun, Zhu, Haiyan, Ye, Li, Feng, Meiqing, Li, Jiyang, Huang, Hai, Tao, Qun, Ye, Dan, Sun, Lee-Hwei K., Sun, Bill N. C., Sun, Cecily R. Y., Han, Guizhen, Liu, Yuanyuan, Yao, Minghui, Zhou, Pei, Ju, Dianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747110/ https://www.ncbi.nlm.nih.gov/pubmed/23977338 http://dx.doi.org/10.1371/journal.pone.0072673 |
Ejemplares similares
-
Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model
por: Chetty, Manoranjenni, et al.
Publicado: (2015) -
Ability of Recombinant Human Catalase to Suppress Inflammation of the Murine Lung Induced by Influenza A
por: Shi, Xunlong, et al.
Publicado: (2014) -
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021) -
Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018) -
Pharmacokinetic‐pharmacodynamic modelling of the anti‐FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic
por: Lledo‐Garcia, Rocio, et al.
Publicado: (2021)